Community Blood Council of New Jersey Licenses SafeTrace(R) Donor Management System DENVER, Aug. 25 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), has signed an agreement with Community Blood Council of New Jersey ("CBC-NJ") to provide CBC-NJ with its SafeTrace(R) donor management system. Terms were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Jim Gosnay, CEO of Community Blood Council of New Jersey, stated, "Our staff selected Wyndgate's SafeTrace donor management system for its comprehensive safety features, as well as its application capabilities, which will facilitate the automation of many of the manual processes currently being performed in our donor service. Wyndgate, with its expertise in the blood bank industry, has successfully developed software to manage the complexities of our donor facility. Community Blood Council of New Jersey decided to purchase Wyndgate's system because of its blood bank market experience, application functionality, product lifecycle, implementation experience and product support. Most importantly, Wyndgate was able to deploy our needs for an Application Service Provider (ASP) through Hemo-Net, a provider of blood donor software solutions, which required no outlay by CBC-NJ for ancillary hardware, third-party software or other required yearly services." Wm. Scott Dustin, Vice President of Sales & Marketing for Wyndgate Technologies, said, "We are very pleased to announce this major agreement with Community Blood Council of New Jersey, a prestigious community blood center in central New Jersey. Through our relationship with Hemo-Net, Wyndgate is able to provide our customers with another option for deploying our SafeTrace donor software solution. This relationship highlights Wyndgate's commitment to quality, safety and service, by partnering with CBC-NJ and Hemo-Net to optimize donor operations." About Community Blood Council of New Jersey Community Blood Council of New Jersey is located in the Trenton, Mercer County area serving New Jersey, and also the Bucks County area serving Pennsylvania. CBC-NJ has provided blood support in the region for over 30 years. For more information about Community Blood Council of New Jersey, visit http://www.communitybloodcouncil.org/. About Hemo-Net, LLC Hemo-Net offers more than 30 years of technical computer experience, specializing in blood donor management and transfusion medicine software applications. As an application service provider, Hemo-Net partners with Wyndgate Technologies to provide quality service in helping blood centers advance their donor tracking, safety and disaster protection. Hemo-Net is a Bonfils Blood Center subsidiary. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx(R)* advanced transfusion management system and the SafeTrace donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000; or Investor Relations, John Nesbett or Jordan Silverstein, both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site: http://www.communitybloodcouncil.org/ Web site: http://www.peoplemed.com/ Web site: http://www.wyndgate.com/ Web site: http://www.globalmedtech.com/

Copyright